DISHMAN CARBOGEN AMCIS
|
The Current P/E Ratio of DISHMAN CARBOGEN AMCIS is -22.94.
Share Price | ₹254.7 | Jan 13,2025 |
Market Cap | ₹3,992.9 Cr | |
Earnings-TTM | ₹-174.0 Cr | TTM-Consolidated Results |
Price/Earnings | -22.94x | Calculated as Market Cap/Earnings |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PE (Price/Earnings) ratio of DISHMAN CARBOGEN AMCIS
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹3,992.9 Cr] as on Jan 13,2025
(/) Earnings [ ₹-174.0 Cr] based on TTM-Consolidated Results
(=) P/E Ratio [ -22.94x ]
Thus, for DISHMAN CARBOGEN AMCIS , the investors are currently willing to pay -22.94 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of DISHMAN CARBOGEN AMCIS !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of DISHMAN CARBOGEN AMCIS over the last five years.
Historical PE (Price/Earnings) ratio chart of DISHMAN CARBOGEN AMCIS
PE Ratio Performance Analysis for DISHMAN CARBOGEN AMCIS
- DISHMAN CARBOGEN AMCIS 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 33.30x.
- DISHMAN CARBOGEN AMCIS 's operated at median p/e ratio of 0x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, DISHMAN CARBOGEN AMCIS 's p/e ratio peaked in Mar2022 at 161.2x.
- DISHMAN CARBOGEN AMCIS 's p/e ratio hit its five-year low in Mar2024 of 0x.
How does DISHMAN CARBOGEN AMCIS 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
---|---|---|---|
DISHMAN CARBOGEN AMCIS | -174.03 | -22.94 | 3,992.9 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 11,136.50 | 37.62 | 418,936.0 |
CIPLA LTD | 4,485.22 | 25.91 | 116,200.0 |
DR REDDYS LABORATORIES LTD | 5,406.80 | 20.59 | 111,325.0 |
ZYDUS LIFESCIENCES LTD | 4,298.90 | 22.81 | 98,037.4 |
DIVIS LABORATORIES LTD | 1,836.00 | 82.87 | 152,157.0 |
MANKIND PHARMA LTD | 2,124.86 | 50.30 | 106,880.0 |
TORRENT PHARMACEUTICALS LTD | 1,802.00 | 60.83 | 109,617.0 |
LUPIN LTD | 2,651.94 | 37.06 | 98,275.2 |
AUROBINDO PHARMA LTD | 3,598.83 | 18.75 | 67,480.4 |
ABBOTT INDIA LTD | 1,284.66 | 47.22 | 60,664.8 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs DISHMAN CARBOGEN AMCIS 's P/E Ratio
Top 10 Industry Peers | PE Ratio |
---|---|
Min industry PE | -22.94x |
Max industry PE | 82.87x |
Median industry PE | 37.06x |
Average industry PE | 34.64x |
You may also like the below Video Courses